# Design Therapeutics, Inc.: Form 8-K, filed Jun 16, 2022

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2022-06-16
- Accepted by EDGAR: Jun 16, 2022, 16:25 ET
- Period: 2022-06-15
- Accession: 0000950170-22-011751
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/dsgn-20220615.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000095017022011751/dsgn-20220615.htm

Filed Jun 16, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-011751. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
